BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10084411)

  • 41. [Bilateral uveitis with definitive hypotony caused by systemic cidofovir].
    Rapp P; Pilon F; Chiambaretta F; Ménérath JM; Jacomet C
    J Fr Ophtalmol; 2003 Sep; 26(7):717-9. PubMed ID: 13130259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of reactivation of cytomegalovirus retinitis in an AIDS patient, during and after stopping long-term cidofovir treatment: case report.
    Papastamopoulos V; Botsis C; Paparizos VA; Kyriakis KP; Zagoraios Y; Stavrianeas NG
    J Chemother; 2000 Jun; 12(3):258-60. PubMed ID: 10877523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
    Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
    Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of CMV infections in HIV-infected patients.
    Hoy J
    Adv Exp Med Biol; 1999; 458():77-87. PubMed ID: 10549381
    [No Abstract]   [Full Text] [Related]  

  • 45. New therapies for cytomegalovirus retinitis.
    Schwartz DM
    Int Ophthalmol Clin; 1996; 36(2):1-9. PubMed ID: 8950629
    [No Abstract]   [Full Text] [Related]  

  • 46. [Ocular complications of the virostatic drug cidofovir].
    Hackethal U; Holzapfel C; Gerding H; Husstedt IW
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):391-5. PubMed ID: 12830392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A very promising, possibly toxic drug.
    Treat Rev; 1995; (no 19):5. PubMed ID: 11362757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacia and Upjohn and Gilead sciences receive European recommendation for cidofovir.
    AIDS Patient Care STDS; 1997 Apr; 11(2):102. PubMed ID: 11361752
    [No Abstract]   [Full Text] [Related]  

  • 49. Lack of efficacy of cidofovir in treating AIDS-related cytomegalovirus retinitis after long-term treatment with ganciclovir.
    Schürmann D; Bergmann F; Grobusch MP; Behnsch M; Liekfeld A
    AIDS; 1998 Apr; 12(6):678-9. PubMed ID: 9583613
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report.
    Rahhal FM; Arevalo JF; Chavez de la Paz E; Munguia D; Azen SP; Freeman WR
    Ann Intern Med; 1996 Jul; 125(2):98-103. PubMed ID: 8678386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ophthalmic complications of HIV/AIDS.
    Vaghjimal A
    Postgrad Med J; 1997 Jul; 73(861):448. PubMed ID: 9338041
    [No Abstract]   [Full Text] [Related]  

  • 52. Management of CMV retinitis in HIV infected patients.
    Katlama C
    Genitourin Med; 1997 Jun; 73(3):169-73. PubMed ID: 9306895
    [No Abstract]   [Full Text] [Related]  

  • 53. Ocular side-effects from systemic HPMPC (Cidofovir) for a non-ocular cytomegalovirus infection.
    Scott RA; Pavesio C
    Am J Ophthalmol; 2000 Jul; 130(1):126-7. PubMed ID: 11004276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytomegalovirus iritis.
    Cheng L; Rao NA; Keefe KS; Avila CP; Macdonald JC; Freeman WR
    Ophthalmic Surg Lasers; 1998 Nov; 29(11):930-2. PubMed ID: 9824866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local therapy for cytomegalovirus retinitis.
    Smith CL
    Ann Pharmacother; 1998 Feb; 32(2):248-55. PubMed ID: 9496411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cidofovir for AIDS-related retinitis.
    Am Fam Physician; 1996 Nov; 54(6):2124. PubMed ID: 8967318
    [No Abstract]   [Full Text] [Related]  

  • 57. Update on treatment of CMV retinitis.
    Feinberg J
    AIDS Clin Care; 1995 Sep; 7(9):71-3, 75, 78. PubMed ID: 11362779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A rocky road for nucleotide analogs.
    Cadman J
    GMHC Treat Issues; 1998 Sep; 12(9):10-2. PubMed ID: 11365803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
    Cherrington JM; Fuller MD; Lamy PD; Miner R; Lalezari JP; Nuessle S; Drew WL
    J Infect Dis; 1998 Dec; 178(6):1821-5. PubMed ID: 9815243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nephrogenic diabetes insipidus in a patient taking cidofovir.
    Schliefer K; Rockstroh JK; Spengler U; Sauerbruch T
    Lancet; 1997 Aug; 350(9075):413-4. PubMed ID: 9259663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.